Saturday, September 30, 2023 11:20:14 AM
Korenko tweeted the following which I take to mean the July-Sept summary will be given in the second half of Oct.
But I hope we see some hint of their take on the Friday meeting in a tweet. Something as little as, 'great meeting with the FDA'. But I'm not going to worry if we don't see that. This isn't really the make or break meeting in terms of getting what we need to get done done. The biggest problem we have now is the schedule and how any government shutdown will affect it. If the government does shutdown and its less than a week I don't think it will have any impact on us because gentoxicity tests will take at least that long. But if it goes on a month or more we will likely be impacted as there will be a big backlog at the FDA and the FDA employees will come back to a flaming turd situation that they didn't ask for and have to clean up. Needless to say moral will be low.
But I hope we see some hint of their take on the Friday meeting in a tweet. Something as little as, 'great meeting with the FDA'. But I'm not going to worry if we don't see that. This isn't really the make or break meeting in terms of getting what we need to get done done. The biggest problem we have now is the schedule and how any government shutdown will affect it. If the government does shutdown and its less than a week I don't think it will have any impact on us because gentoxicity tests will take at least that long. But if it goes on a month or more we will likely be impacted as there will be a big backlog at the FDA and the FDA employees will come back to a flaming turd situation that they didn't ask for and have to clean up. Needless to say moral will be low.
Vivos CEO Dr. Mike Korenko will be attending the Veterinary Society Conference (VCS) in Reno, NV October 12 - 14, 2023.
— Vivos Inc. (@VivosIncUSA) September 28, 2023
We’re planning on sharing a Q & A interview with him that will go out in our 3rd Quarter (Q3) update to be issued in the last 1/2 of the month.#Cancer $RDGL
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
